In Utero MRI Identifies Impaired Second Trimester Subplate Growth in Fetuses with Congenital Heart Disease. (28th October 2021)

• Record Type: Journal Article
• Authors: Wu, Yao; Lu, Yuan-Chiao; Kapse, Kushal; Jacobs, Marni; Andescavage, Nickie; Donofrio, Mary T; Lopez, Catherine; Quistorff, Jessica Lynn; Vezina, Gilbert; Krishnan, Anita; du Plessis, Adré J; Limperopoulos, Catherine
• Is Part Of: Cerebral cortex. Volume 32:Number 13(2022)
• Page Start: 2858
• Page End: 2867
• Publication Date: 2021-10-28
• Subjects: cortical sulcal depth -- subplate thickness -- subplate volume; Cerebral cortex -- Periodicals; Brain -- Periodicals; 612.825
• DOI: 10.1093/cercor/bhab386
• Languages: English
• ISSNs: 1047-3211

Abstract

Abstract: : The subplate is a transient brain structure which plays a key role in the maturation of the cerebral cortex. Altered brain growth and cortical development have been suggested in fetuses with complex congenital heart disease (CHD) in the third trimester. However, at an earlier gestation, the putative role of the subplate in altered brain development in CHD fetuses is poorly understood. This study aims to examine subplate growth (i.e., volume and thickness) and its relationship to cortical sulcal development in CHD fetuses compared with healthy fetuses by using 3D reconstructed fetal magnetic resonance imaging. We studied 260 fetuses, including 100 CHD fetuses (22.3–32 gestational weeks) and 160 healthy fetuses (19.6–31.9 gestational weeks). Compared with healthy fetuses, CHD fetuses had 1) decreased global and regional subplate volumes and 2) decreased subplate thickness in the right hemisphere overall, in frontal and temporal lobes, and insula. Compared with fetuses with two-ventricle CHD, those with single-ventricle CHD had reduced subplate volume and thickness in right occipital and temporal lobes. Finally, impaired subplate growth was associated with disturbances in cortical sulcal development in CHD fetuses. These findings suggested a potential mechanistic pathway and early biomarker for the third-trimester failure of brain development in fetuses with complex CHD. Significance Statement: Our findings provide an early biomarker for brain maturational failure in fetuses with congenital heart disease, which may guide the development of future prenatal interventions aimed at reducing neurological compromise of prenatal origin in this high-risk population.